Clinical trial
Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
NCT00239902 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00239902 |
|---|---|
| Title | Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients |
| Official title | Two-year Extension of a One-year, Multicenter, Randomized, Partially-blinded Study of the Safety and Efficacy of FTY720 Combined With Corticosteroids and Full or Reduced-dose Cyclosporine, USP [Modified] (Novartis Brand) in de Novo Adult Renal Transplant Recipients |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Renal Transplantation |
| Intervention type | Drug |
| Interventions | FTY720 |
| Enrollment | 396 |
| Start date | May 1, 2002 |
| Primary completion | Nov 1, 2004 |
| First posted | Oct 17, 2005 |
| Last update posted | Nov 2, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: